Q&A: How Do You Protect Your IP?

Medical device companies are in a race to benefit humanity — and impress potential investors or acquirers in the process. They must stand out enough to be noticed, but this can put their good ideas on the radar of potential copiers. They must convince the U.S. Food and Drug Administration (FDA) that their products are safe, while convincing buyers that their products are effective and different. How should medical device companies protect their intellectual property (IP) in this labyrinth? In this Q&A, Philip Nelson, a partner with Knobbe Martens, provides some insights for device companies facing these issues.